ANTHONY CENTLIVRE: Open Payments
NPI 1255051231 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 108 payments from 12 companies in 2025. Trend: 2023 $1,419 · 2024 $900 · 2025 $1,268
Food & beverage: $1,208Education: $59
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 61 | $455 |
| Otsuka America Pharmaceutical, Inc. | 9 | $211 |
| Vanda Pharmaceuticals Inc. | 10 | $143 |
| E.R. Squibb & Sons, L.L.C. | 17 | $139 |
| Novo Nordisk Inc | 1 | $125 |
| Alkermes, Inc. | 3 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Orexo US, Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: REXULTI, ABILIFY ASIMTUFII, Ozempic, FANAPT, ARISTADA, CAPLYTA, COBENFY, HETLIOZ.
Industry payments across IN — which companies pay providers there.
